In practical terms, labeled prescribing information provides clearer safety boundaries than non-approved products
Apr 07, 2026, 08:00 ET Wegovy HD available through 70,000+ US pharmacies, NovoCare Pharmacy, select telehealth providers, and more STEP UP trial data showed average weight loss of ~21% with Wegovy HD at 72 weeks in adults with obesity if all patients stayed on treatment * and ~19% regardless of whether patients stayed on treatment **1 Wegovy HD further expands the offerings for patients within the Wegovy label, inclusive of multiple formulations, including Wegovy pill, and indications not available with other GLP-1 weight loss medicines PLAINSBORO, N.J., April 7, 2026 /PRNewswire/ -- Wegovy HD (semaglutide) injection 7.2 mg is available now nationwide, delivering the highest weight loss of any Wegovy injection to date
The ice packs were melted but remained cold to the touch and appeared to keep the medication chilled
GLP-1 therapy for obesity without diabetes
Drugbank.com